Run for Rare: 3billion’s In-House Marathon Challenge for Rare Disease Day 2025

In honor of Rare Disease Day 2025, 3billion is proud to launch the “Run for Rare” marathon challenge—a company-wide initiative aimed at raising awareness about rare diseases and supporting patients in their diagnostic journeys. This challenge symbolizes our commitment to improving access to genetic testing and underscores the urgency of accelerating diagnosis for individuals facing rare conditions.

Why We Run

Rare Disease Day, observed annually on February 28, highlights the challenges faced by over 300 million people worldwide living with a rare disease. Many of these patients endure prolonged diagnostic odysseys, often spanning years before receiving an accurate diagnosis. At 3billion, we are dedicated to transforming this reality by harnessing genetic testing and AI-driven insights to shorten the diagnostic timeline and improve patient outcomes.

To symbolize our commitment, our team will collectively run 228 kilometers, a distance inspired by the Rare Disease Day date 2/28. Through this initiative, we stand in solidarity with rare disease patients and their families, raising awareness within our organization and beyond.

Challenge Details

Impact: 3billion will sponsor Whole Exome Sequencing (WES) tests to Asan Medical Centre to support rare disease patients in their diagnostic journey.

Duration: February 17 – February 28 (11 days)

Participants: Open to all 3billion team members

Goal: Run a cumulative total of 228KM

Final Results

Total Participants: 33

Total Distance Run: 287 KM (average of 8.7 KM per participant)

Total Number of Diagnostic Tests Sponsored: 28 WES tests for diagnosis

This challenge was more than just a run—it was a step toward bridging the diagnostic gap for rare disease patients.

Our Commitment in Action

Beyond raising awareness, “Run for Rare” embodies our mission in a tangible way. By linking our efforts to direct patient support, we are providing 28 free WES tests—a total diagnostic testing value of 30 million KRW (approximately $22,500 USD). These tests will help individuals receive precise genetic diagnoses, paving the way for timely interventions and potential treatment options.

The Culture at 3billion

At 3billion, our commitment to rare disease patients is reflected in our team culture. This marathon challenge is just one example of how we embody our mission—not just in the lab and the office, but in action. Whether it’s through groundbreaking research, community initiatives, or workplace wellness challenges like “Run for Rare,” our team thrives on making a difference.

We foster an environment of collaboration, innovation, and purpose-driven work. Employees from diverse backgrounds come together to make a real impact, working at the intersection of healthcare and technology to push the boundaries of genetic diagnostics.

Looking Ahead

The success of “Run for Rare” reinforces our dedication to the rare disease community. As we reflect on this achievement, we remain committed to advancing genetic testing and improving the lives of patients worldwide. Every step we take brings us closer to a future where no rare disease patient is left undiagnosed.

Take the Next Step with 3billion

At 3billion, we provide comprehensive genetic testing solutions, including Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS), to help identify rare conditions with precision and speed. If you or someone you know is struggling with an undiagnosed condition, reach out to us today. Let’s work together to bring clarity to rare disease diagnostics.

Leave your details here to learn more about our WES and WGS services and how 3billion can support you in your journey.